Ppargc1a (PPARG coactivator 1 alpha) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Ppargc1a (PPARG coactivator 1 alpha) Rattus norvegicus
Analyze
Symbol: Ppargc1a
Name: PPARG coactivator 1 alpha
RGD ID: 620925
Description: Enables several functions, including alpha-tubulin binding activity; nuclear estrogen receptor binding activity; and peroxisome proliferator activated receptor binding activity. Involved in several processes, including cellular response to hexose stimulus; cellular response to organic cyclic compound; and regulation of smooth muscle cell proliferation. Located in several cellular components, including apical dendrite; cytosolic ribosome; and euchromatin. Used to study several diseases, including fatty liver disease (multiple); glucose metabolism disease (multiple); heart disease (multiple); neurodegenerative disease (multiple); and sciatic neuropathy. Biomarker of several diseases, including Huntington's disease; glucose metabolism disease (multiple); placental insufficiency; primary biliary cholangitis; and renal fibrosis. Human ortholog(s) of this gene implicated in several diseases, including macular degeneration; malignant fibrous histiocytoma; neurodegenerative disease (multiple); non-alcoholic fatty liver disease; and type 2 diabetes mellitus. Orthologous to human PPARGC1A (PPARG coactivator 1 alpha); PARTICIPATES IN aldosterone signaling pathway; mTOR signaling pathway; Huntington's disease pathway; INTERACTS WITH (+)-schisandrin B; (+)-taxifolin; (-)-epigallocatechin 3-gallate.
Type: protein-coding
RefSeq Status: PROVISIONAL
Previously known as: LRPGC1; peroxisome proliferative activated receptor gamma coactivator 1; peroxisome proliferative activated receptor, gamma, coactivator 1; peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; peroxisome proliferator-activated receptor gamma coactivator 1-alpha; peroxisome proliferator-activated receptor gamma, coactivator 1 alpha; PGC-1-alpha; PGC-1alpha; PGC-1v; PGCvf; PGCvf-1; PGCvf1; PPAR gamma coactivator 1alpha variant form-1; PPAR-gamma coactivator 1-alpha; PPARGC-1-alpha; Ppargc1; Ppargc1a-vf1
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21458,860,752 - 59,516,525 (+)NCBImRatBN7.2
mRatBN7.2 Ensembl1458,861,144 - 59,512,656 (+)Ensembl
Rnor_6.01463,095,291 - 63,190,688 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1463,095,720 - 63,187,009 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01463,182,479 - 63,286,252 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41464,278,115 - 64,370,912 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11464,280,505 - 64,373,303 (+)NCBI
Celera1458,516,257 - 58,607,916 (+)NCBICelera
Cytogenetic Map14q11NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
abdominal obesity-metabolic syndrome  (IEP)
acute kidney failure  (ISO)
age related macular degeneration  (ISS)
Albuminuria  (ISO)
Alzheimer's disease  (IDA,ISO)
amblyopia  (IEP)
amyotrophic lateral sclerosis  (ISO)
Bowen's Disease  (ISO)
Brain Injuries  (IEP,ISO)
Cardiomegaly  (IEP,ISO)
cardiomyopathy  (ISS)
cardiovascular system disease  (ISO)
Carotid Artery Injuries  (IDA,ISO)
chronic kidney disease  (ISO)
chronic obstructive pulmonary disease  (ISO)
colitis  (IDA)
congenital hypothyroidism  (IEP)
congestive heart failure  (ISO)
Diabetic Nephropathies  (ISO)
diabetic retinopathy  (IDA,IEP)
dilated cardiomyopathy  (IDA)
Diseases of the Aged  (IEP)
Experimental Diabetes Mellitus  (IDA,IEP,IMP,ISO)
fatty liver disease  (IDA,IEP,ISO)
Fetal Growth Retardation  (IEP)
glucose intolerance  (ISO)
heart disease  (IDA)
Huntington's disease  (IDA,IEP,ISO)
hyperglycemia  (IDA,IEP,ISO)
hyperthyroidism  (IEP)
Insulin Resistance  (IEP,ISO)
Kearns-Sayre syndrome  (ISO)
kidney cancer  (ISO)
kidney failure  (IDA)
Kidney Reperfusion Injury  (IDA)
Left Ventricular Hypertrophy  (ISO)
Lewy body dementia  (ISO)
macular degeneration  (ISO)
malignant fibrous histiocytoma  (ISO)
melanoma  (ISO)
Metabolic Syndrome  (IEP)
Muscular Dystrophy, Animal  (ISO)
myocardial infarction  (IEP,ISO)
Myocardial Reperfusion Injury  (ISO)
nephrotic syndrome  (IEP)
neuronal ceroid lipofuscinosis 1  (ISO)
non-alcoholic fatty liver disease  (IDA,ISO)
obesity  (IDA,IEP,ISO)
Parkinson's disease  (ISO)
Parkinsonism  (ISO)
placental insufficiency  (IEP)
prediabetes syndrome  (IEP)
primary biliary cholangitis  (IEP)
pulmonary emphysema  (ISO)
renal fibrosis  (IEP)
Right Ventricular Hypertrophy  (IEP)
Sarcopenia  (IEP)
schizophrenia  (ISO)
sciatic neuropathy  (IDA)
Sepsis  (IEP)
Sleep Initiation and Maintenance Disorders  (ISO)
Spinal Cord Injuries  (IDA)
Takotsubo Cardiomyopathy  (IEP)
type 1 diabetes mellitus  (ISO)
type 2 diabetes mellitus  (IDA,IEP,ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-artemisinin  (ISO)
(+)-catechin  (ISO)
(+)-schisandrin B  (EXP)
(+)-taxifolin  (EXP)
(-)-epigallocatechin 3-gallate  (EXP,ISO)
(20S)-ginsenoside Rg3  (EXP)
(R)-adrenaline  (EXP)
(R)-lipoic acid  (EXP,ISO)
(R)-noradrenaline  (EXP,ISO)
(S)-nicotine  (EXP,ISO)
1,1-dichloroethene  (ISO)
1,2-dimethylhydrazine  (ISO)
1,4-dithiothreitol  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
1-stearoyl-2-arachidonoyl-sn-glycerol  (ISO)
11-deoxycorticosterone  (ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-hydroxy-17-methylestra-4,9,11-trien-3-one  (ISO)
1D-myo-inositol 1-phosphate  (ISO)
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one  (EXP,ISO)
1H-pyrazole  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (EXP)
2-amino-2-deoxy-D-glucopyranose  (EXP,ISO)
2-butoxyethanol  (ISO)
2-chloroethanol  (ISO)
3',5'-cyclic AMP  (EXP,ISO)
3,3',4,4',5-pentachlorobiphenyl  (EXP)
3,3',5-triiodo-L-thyronine  (EXP,ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4,6-dioxoheptanoic acid  (ISO)
4-hydroxyphenyl retinamide  (ISO)
4-phenylbutyric acid  (EXP,ISO)
5-(2-chloroethyl)-4-methylthiazole  (ISO)
5-aminoimidazole-4-carboxamide  (EXP)
5-aza-2'-deoxycytidine  (ISO)
5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid  (ISO)
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide  (EXP,ISO)
6-propyl-2-thiouracil  (EXP)
8-bromo-3',5'-cyclic GMP  (ISO)
9-cis-retinoic acid  (ISO)
acadesine  (EXP,ISO)
acarbose  (ISO)
acetamide  (EXP)
acrolein  (EXP)
acrylamide  (ISO)
adenosine  (ISO)
adenosine 5'-monophosphate  (ISO)
afimoxifene  (ISO)
aflatoxin B1  (ISO)
Aflatoxin B2 alpha  (ISO)
AICA ribonucleotide  (EXP,ISO)
albuterol  (ISO)
aldehydo-D-glucosamine  (EXP,ISO)
aldehydo-D-glucose  (EXP,ISO)
aldosterone  (EXP)
all-trans-retinal  (ISO)
all-trans-retinoic acid  (ISO)
all-trans-retinol  (ISO)
alloxan  (EXP)
allyl isothiocyanate  (ISO)
alpha,alpha-trehalose  (ISO)
alpha-D-galactose  (EXP)
aminoguanidine  (EXP,ISO)
amiodarone  (ISO)
ammonium chloride  (EXP)
anthra[1,9-cd]pyrazol-6(2H)-one  (ISO)
antimycin A  (ISO)
aristolochic acid  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenous acid  (EXP,ISO)
asiatic acid  (ISO)
aspartame  (ISO)
atorvastatin calcium  (EXP,ISO)
atrazine  (EXP,ISO)
benfotiamine  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (ISO)
Benzo[ghi]perylene  (ISO)
berberine  (ISO)
beta-D-glucosamine  (EXP,ISO)
Betanin  (EXP)
bezafibrate  (ISO)
biotin  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
bortezomib  (ISO)
bosentan  (ISO)
bromobenzene  (EXP)
bucladesine  (ISO)
buta-1,3-diene  (ISO)
butan-1-ol  (ISO)
butan-2-one  (ISO)
butanal  (ISO)
Butylbenzyl phthalate  (ISO)
C60 fullerene  (EXP)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (EXP)
calcitriol  (EXP,ISO)
cannabidiol  (ISO)
capsaicin  (EXP,ISO)
captan  (ISO)
carbamazepine  (ISO)
carbon monoxide  (EXP,ISO)
carbon nanotube  (ISO)
carfilzomib  (ISO)
carvedilol  (EXP)
casticin  (ISO)
chicoric acid  (EXP)
CHIR 99021  (ISO)
chlormidazole  (ISO)
chloroprene  (ISO)
chlorpyrifos  (EXP,ISO)
cholate  (EXP)
choline  (ISO)
chromium(6+)  (ISO)
ciglitazone  (ISO)
ciguatoxin CTX1B  (ISO)
cisplatin  (EXP,ISO)
clenbuterol  (EXP,ISO)
clofibrate  (ISO)
cobalt dichloride  (EXP)
colforsin daropate hydrochloride  (ISO)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
copper(II) sulfate  (ISO)
cortisol  (ISO)
cortisone  (ISO)
creatine  (ISO)
crocidolite asbestos  (ISO)
curcumin  (EXP)
cyclosporin A  (EXP,ISO)
cyproconazole  (EXP)
D-glucose  (EXP,ISO)
D-glucurono-6,3-lactone  (ISO)
dapagliflozin  (EXP)
DDE  (ISO)
DDT  (ISO)
decanoic acid  (ISO)
dehydroepiandrosterone  (EXP)
Delta(9)-tetrahydrocannabinolic acid  (ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (EXP)
Di-n-hexyl phthalate  (EXP)
diarsenic trioxide  (EXP,ISO)
dibutyl phthalate  (EXP,ISO)
dichloroacetic acid  (ISO)
dichloromethane  (ISO)
diclofenac  (ISO)
diethylstilbestrol  (ISO)
dihydrofolic acid  (ISO)
dioxygen  (EXP,ISO)
disodium selenite  (ISO)
dodecanoic acid  (ISO)
dorsomorphin  (EXP,ISO)
doxorubicin  (EXP,ISO)
edaravone  (EXP)
elemental selenium  (ISO)
ellagic acid  (ISO)
enalapril  (EXP)
endosulfan  (EXP)
enilconazole  (ISO)
epoxiconazole  (EXP)
Erythropoietin  (ISO)
ethanol  (EXP,ISO)
etoposide  (ISO)
farnesol  (EXP)
fenofibrate  (ISO)
fenoterol  (ISO)
fenpyroximate  (ISO)
ferulic acid  (EXP,ISO)
flavonoids  (ISO)
fluoxastrobin  (ISO)
folic acid  (ISO)
folpet  (ISO)
fructose  (EXP,ISO)
fulvestrant  (EXP,ISO)
galactose  (EXP)
gamma-hexachlorocyclohexane  (ISO)
Genipin  (ISO)
Geniposide  (ISO)
ginsenoside Rg2  (ISO)
glucagon  (EXP)
glucose  (EXP,ISO)
glutathione  (ISO)
GW 1929  (ISO)
GW 501516  (ISO)
haloperidol  (ISO)
harmine  (ISO)
hemin  (EXP)
herbicide  (ISO)
hesperidin  (EXP)
hexadecanoic acid  (EXP,ISO)
Honokiol  (ISO)
hydrogen cyanide  (ISO)
hydrogen peroxide  (EXP,ISO)
icariin  (EXP,ISO)
ICI 118551  (ISO)
imidacloprid  (ISO)
indole-3-methanol  (EXP)
indometacin  (ISO)
ionomycin  (EXP)
iprodione  (EXP)
isobutanol  (ISO)
isoniazide  (ISO)
isoprenaline  (EXP,ISO)
isoxazoles  (ISO)
kaempferol  (ISO)
ketotifen  (ISO)
kresoxim-methyl  (ISO)
L-1,4-dithiothreitol  (ISO)
L-ascorbic acid  (ISO)
L-glutamic acid  (ISO)
L-methionine  (EXP)
lead diacetate  (ISO)
leflunomide  (ISO)
Licarin A  (ISO)
limonene  (ISO)
linagliptin  (ISO)
linoleic acid  (EXP,ISO)
lipoic acid  (EXP,ISO)
lipopolysaccharide  (EXP,ISO)
liraglutide  (ISO)
losartan  (EXP)
lovastatin  (ISO)
luzindole  (ISO)
LY294002  (EXP,ISO)
mabuterol  (ISO)
Magnolol  (EXP)
malic acid  (ISO)
malonic acid  (ISO)
manganese atom  (EXP,ISO)
manganese(0)  (EXP,ISO)
manganese(II) chloride  (EXP,ISO)
mangiferin  (ISO)
melatonin  (EXP,ISO)
meldonium  (EXP,ISO)
metformin  (ISO)
methamphetamine  (ISO)
methyl methanesulfonate  (ISO)
methylglyoxal  (EXP,ISO)
metoprolol  (EXP)
monascin  (ISO)
mono(2-ethylhexyl) phthalate  (ISO)
monosodium L-glutamate  (EXP,ISO)
myo-inositol hexakisphosphate  (ISO)
N(6)-butyryl-cAMP  (EXP)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
N-acetyl-L-cysteine  (EXP,ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-methyl-4-phenylpyridinium  (EXP,ISO)
naringin  (EXP)
nebivolol  (ISO)
nickel atom  (ISO)
nickel sulfate  (ISO)
nicotinamide  (EXP,ISO)
nicotine  (EXP,ISO)
nicotinic acid  (ISO)
nitrites  (EXP)
nitrogen dioxide  (ISO)
nitroprusside  (ISO)
NSC 23766  (ISO)
O-acetyl-L-carnitine  (ISO)
octadecanoic acid  (ISO)
olanzapine  (EXP)
oleic acid  (ISO)
orientin  (ISO)
oxaloacetic acid  (ISO)
oxidopamine  (ISO)
ozone  (EXP)
paracetamol  (ISO)
paraquat  (EXP,ISO)
pentachlorophenol  (ISO)
perfluorododecanoic acid  (EXP)
perfluorohexanesulfonic acid  (ISO)
perfluorononanoic acid  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (EXP,ISO)
peroxynitrous acid  (EXP)
phenobarbital  (ISO)
phenylmercury acetate  (ISO)
picloram  (ISO)
picoxystrobin  (ISO)
pioglitazone  (EXP,ISO)
pirinixic acid  (ISO)
platycodin D  (ISO)
potassium chloride  (EXP)
potassium cyanide  (ISO)
potassium dichromate  (EXP,ISO)
prazosin  (ISO)
pregnenolone 16alpha-carbonitrile  (ISO)
prochloraz  (EXP)
progesterone  (EXP,ISO)
propiconazole  (ISO)
propionic acid  (ISO)
propranolol  (ISO)
prostaglandin D2  (ISO)
prostaglandin I2  (ISO)
pterostilbene  (ISO)
puerarin  (EXP)
pyridaben  (ISO)
pyridoxine  (EXP,ISO)
pyrroloquinoline quinone  (EXP,ISO)
pyruvic acid  (ISO)
quercetin  (EXP,ISO)
reactive oxygen species  (EXP)
rebaudioside A  (ISO)
resveratrol  (EXP,ISO)
riboflavin  (ISO)
rifampicin  (ISO)
rotenone  (EXP,ISO)
S-adenosyl-L-homocysteine  (ISO)
Salmeterol xinafoate  (ISO)
Salvianolic acid A  (EXP,ISO)
salvianolic acid B  (EXP)
SB 431542  (ISO)
SB-239063  (EXP)
selenium atom  (ISO)
silicon atom  (ISO)
silicon dioxide  (ISO)
sirolimus  (EXP,ISO)
sirtinol  (EXP,ISO)
sodium arsenate  (ISO)
sodium arsenite  (EXP,ISO)
sodium hydrogensulfite  (EXP)
splitomicin  (EXP)
staurosporine  (ISO)
steviol  (ISO)
stevioside  (ISO)
streptozocin  (EXP,ISO)
sulforaphane  (ISO)
sulfur dioxide  (EXP)
sunitinib  (ISO)
T-2 toxin  (EXP,ISO)
tamoxifen  (ISO)
taurine  (EXP,ISO)
tauroursodeoxycholic acid  (EXP,ISO)
telmisartan  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP,ISO)
testosterone enanthate  (EXP)
tetrachloromethane  (EXP)
tetradecanoic acid  (ISO)
tetraphene  (ISO)
thioacetamide  (EXP)
titanium dioxide  (ISO)
topotecan  (ISO)
trichlopyr  (ISO)
trichloroethene  (EXP)
trichostatin A  (ISO)
triclosan  (ISO)
trifloxystrobin  (ISO)
trilobatin  (EXP)
triphenylstannane  (EXP,ISO)
Triptolide  (ISO)
troglitazone  (EXP,ISO)
tunicamycin  (ISO)
UDP-alpha-D-glucuronic acid  (ISO)
valproic acid  (ISO)
vancomycin  (ISO)
vorinostat  (ISO)
ziram  (EXP)
zoledronic acid  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
adaptive thermogenesis  (IEP)
adipose tissue development  (ISO)
aging  (IEP)
androgen metabolic process  (IEP)
autophagy of mitochondrion  (IEP)
cellular response to caffeine  (IEP)
cellular response to estradiol stimulus  (IEP)
cellular response to fatty acid  (IEP)
cellular response to follicle-stimulating hormone stimulus  (IDA)
cellular response to fructose stimulus  (IEP)
cellular response to glucose stimulus  (IEP)
cellular response to hypoxia  (IEP)
cellular response to interleukin-6  (IEP)
cellular response to ionomycin  (IEP)
cellular response to lipopolysaccharide  (IEP)
cellular response to nitrite  (IEP)
cellular response to oxidative stress  (ISO,ISS)
cellular response to potassium ion  (IEP)
cellular response to resveratrol  (IEP)
cellular response to thyroid hormone stimulus  (IDA,IEP)
cellular response to transforming growth factor beta stimulus  (IDA)
cellular response to tumor necrosis factor  (IEP)
cerebellum development  (IEP)
circadian regulation of gene expression  (ISO,ISS)
energy homeostasis  (ISO,ISS)
fatty acid oxidation  (IEP)
flavone metabolic process  (IEP)
forebrain development  (IEP)
galactose metabolic process  (IEP)
gluconeogenesis  (IEP,ISO,ISS)
mitochondrion organization  (IEP,IMP)
negative regulation of glycolytic process  (IMP)
negative regulation of mitochondrial fission  (IMP)
negative regulation of neuron apoptotic process  (ISO,ISS)
negative regulation of neuron death  (ISO,ISS)
negative regulation of protein phosphorylation  (IMP)
negative regulation of signaling receptor activity  (IMP)
negative regulation of smooth muscle cell migration  (IMP)
negative regulation of smooth muscle cell proliferation  (IMP,ISO)
neuron apoptotic process  (ISO)
positive regulation of ATP biosynthetic process  (ISO,ISS)
positive regulation of cellular respiration  (ISO)
positive regulation of cold-induced thermogenesis  (ISO,ISS)
positive regulation of DNA-binding transcription factor activity  (IBA,ISO,ISS)
positive regulation of fatty acid oxidation  (IMP)
positive regulation of gene expression  (ISO)
positive regulation of mitochondrial DNA metabolic process  (ISO)
positive regulation of mitochondrion organization  (ISO,ISS)
positive regulation of muscle tissue development  (ISO)
positive regulation of podocyte apoptotic process  (IMP)
positive regulation of progesterone biosynthetic process  (IMP)
positive regulation of transcription by RNA polymerase II  (IBA,IMP,ISO,ISS)
positive regulation of transcription, DNA-templated  (IMP,ISO)
positive regulation of vascular associated smooth muscle cell proliferation  (IMP)
regulation of circadian rhythm  (ISO,ISS)
regulation of NMDA receptor activity  (IMP)
regulation of transcription, DNA-templated  (ISO,ISS)
respiratory electron transport chain  (ISO,ISS)
response to activity  (IDA,IEP)
response to cold  (IEP)
response to dietary excess  (ISO)
response to electrical stimulus  (IEP)
response to electrical stimulus involved in regulation of muscle adaptation  (IEP)
response to epinephrine  (IEP)
response to fructose  (IEP)
response to hypoxia  (IEP)
response to ischemia  (IEP)
response to leucine  (IEP)
response to metformin  (IEP)
response to methionine  (IEP)
response to muscle activity  (IEP,ISO,ISS)
response to norepinephrine  (IEP)
response to nutrient levels  (IEP)
response to organic cyclic compound  (IEP)
response to reactive oxygen species  (IEP)
response to starvation  (IEP)
response to thyroid hormone  (IEP)
response to xenobiotic stimulus  (IEP)
skeletal muscle atrophy  (IEP)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
References

References - curated
1. Adachi T, etal., Exp Physiol. 2007 Mar;92(2):449-55. Epub 2006 Dec 7.
2. Agrawal R, etal., Biochim Biophys Acta. 2014 Apr;1842(4):535-46. doi: 10.1016/j.bbadis.2013.12.004. Epub 2013 Dec 15.
3. Alberdi G, etal., Nutrition. 2013 Mar;29(3):562-7. doi: 10.1016/j.nut.2012.09.011. Epub 2012 Dec 28.
4. Amengual-Cladera E, etal., Metabolism. 2012 Aug;61(8):1108-17. doi: 10.1016/j.metabol.2011.12.016. Epub 2012 Mar 7.
5. Ananda S, etal., J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):823-8. doi: 10.1007/s11596-012-1041-3. Epub 2012 Dec 28.
6. Arduini A, etal., Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G119-27. Epub 2011 Mar 17.
7. Ashabi G, etal., Behav Brain Res. 2012 Jun 15;232(1):165-73. doi: 10.1016/j.bbr.2012.04.006. Epub 2012 Apr 9.
8. Atherton PJ, etal., FASEB J. 2005 May;19(7):786-8. Epub 2005 Feb 16.
9. Attia RR, etal., J Biol Chem. 2010 Jan 22;285(4):2375-85. doi: 10.1074/jbc.M109.039081. Epub 2009 Nov 30.
10. Bahi L, etal., J Cell Physiol. 2005 Jun;203(3):589-98.
11. Baker DJ, etal., J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):675-84.
12. Branvold DJ, etal., J Appl Physiol (1985). 2008 Oct;105(4):1218-27. doi: 10.1152/japplphysiol.00997.2007. Epub 2008 Jul 31.
13. Budick-Harmelin N, etal., Lipids Health Dis. 2012 Jul 9;11:66. doi: 10.1186/1476-511X-11-66.
14. Bugger H, etal., Diabetes. 2009 Sep;58(9):1986-97. doi: 10.2337/db09-0259. Epub 2009 Jun 19.
15. Buler M, etal., J Biol Chem. 2012 Jan 13;287(3):1847-60. doi: 10.1074/jbc.M111.302356. Epub 2011 Nov 23.
16. Burgueno AL, etal., J Nutr Biochem. 2013 Jan;24(1):6-13. doi: 10.1016/j.jnutbio.2011.12.008. Epub 2012 May 30.
17. Cao L, etal., Oxid Med Cell Longev. 2012;2012:374346. doi: 10.1155/2012/374346. Epub 2012 Dec 25.
18. Cao S, etal., PLoS One. 2012;7(12):e51709. doi: 10.1371/journal.pone.0051709. Epub 2012 Dec 13.
19. Caton PW, etal., J Endocrinol. 2011 Mar;208(3):273-83. doi: 10.1530/JOE-10-0190. Epub 2011 Jan 6.
20. Che HV, etal., Mol Neurodegener. 2011 Jan 6;6(1):1. doi: 10.1186/1750-1326-6-1.
21. Chen H, etal., J Neuroendocrinol. 2012 Oct;24(10):1356-64. doi: 10.1111/j.1365-2826.2012.02339.x.
22. Chen LW, etal., Neuropharmacology. 2012 Sep;63(4):719-32. doi: 10.1016/j.neuropharm.2012.05.019. Epub 2012 May 24.
23. Chen M, etal., Am J Physiol Cell Physiol. 2009 Apr;296(4):C930-40. doi: 10.1152/ajpcell.00443.2008. Epub 2009 Jan 21.
24. Chen Y, etal., Mol Cell Endocrinol. 2012 Oct 15;362(1-2):11-8. doi: 10.1016/j.mce.2012.03.023. Epub 2012 Apr 5.
25. Chen YJ, etal., Endocrinology. 2008 Sep;149(9):4658-68. Epub 2008 May 29.
26. Chiang MC, etal., Biochim Biophys Acta. 2011 Sep;1812(9):1111-20. Epub 2011 May 30.
27. Chung HW, etal., Nephrol Dial Transplant. 2012 Jun;27(6):2213-25. doi: 10.1093/ndt/gfr613. Epub 2011 Nov 9.
28. Chung N, etal., Can J Physiol Pharmacol. 2012 Dec;90(12):1634-41. doi: 10.1139/y2012-144. Epub 2012 Nov 29.
29. Ciron C, etal., Hum Mol Genet. 2012 Apr 15;21(8):1861-76. Epub 2012 Jan 12.
30. Clark J, etal., BMC Med Genet. 2011 May 19;12:69.
31. Cowell RM, etal., J Comp Neurol. 2007 May 1;502(1):1-18.
32. Cui L, etal., Cell. 2006 Oct 6;127(1):59-69.
33. Dimopoulos N, etal., FEBS Lett. 2007 Oct 2;581(24):4743-8. Epub 2007 Sep 6.
34. Fabregat-Andres O, etal., PLoS One. 2011;6(11):e26913. Epub 2011 Nov 7.
35. Fan YW, etal., Brain Inj. 2012 May 29.
36. Fei J, etal., Atherosclerosis. 2012 Jun;222(2):395-401. doi: 10.1016/j.atherosclerosis.2012.02.040. Epub 2012 Mar 14.
37. Feng H, etal., Exp Physiol. 2013 Mar;98(3):784-95. doi: 10.1113/expphysiol.2012.069286. Epub 2012 Oct 26.
38. Festuccia WT, etal., Am J Physiol Regul Integr Comp Physiol. 2012 Dec 15;303(12):R1277-85. doi: 10.1152/ajpregu.00299.2012. Epub 2012 Oct 24.
39. Frier BC, etal., Am J Physiol Cell Physiol. 2012 Jun 15;302(12):C1772-9. doi: 10.1152/ajpcell.00410.2011. Epub 2012 Apr 11.
40. Gao F, etal., J Cardiovasc Pharmacol. 2012 Jun;59(6):500-6. doi: 10.1097/FJC.0b013e31824c853c.
41. Gao M and Liu D, AAPS J. 2013 Jan;15(1):258-66. doi: 10.1208/s12248-012-9429-3. Epub 2012 Nov 22.
42. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
43. Gayathri SB, etal., Metab Syndr Relat Disord. 2010 Apr;8(2):119-26. doi: 10.1089/met.2009.0040.
44. Gilde AJ, etal., Circ Res 2003 Mar 21;92(5):518-24.
45. GOA data from the GO Consortium
46. Gomez-Arroyo J, etal., Circ Heart Fail. 2013 Jan;6(1):136-44. doi: 10.1161/CIRCHEARTFAILURE.111.966127. Epub 2012 Nov 14.
47. Grimstad T, etal., Scand J Gastroenterol. 2012 Jan;47(1):49-58. Epub 2011 Nov 30.
48. Gundewar S, etal., Circ Res. 2009 Feb 13;104(3):403-11. doi: 10.1161/CIRCRESAHA.108.190918. Epub 2008 Dec 18.
49. Gurd BJ, etal., Am J Physiol Regul Integr Comp Physiol. 2011 Jul;301(1):R67-75. doi: 10.1152/ajpregu.00417.2010. Epub 2011 May 4.
50. Ha CD, etal., Asia Pac J Public Health. 2013 Feb 27.
51. Han JS, etal., Acta Cardiol. 2010 Dec;65(6):639-44.
52. Hasumi H, etal., J Natl Cancer Inst. 2012 Nov 21;104(22):1750-64. doi: 10.1093/jnci/djs418. Epub 2012 Nov 12.
53. Hathorn T, etal., Neurobiol Dis. 2011 Jan;41(1):43-50. doi: 10.1016/j.nbd.2010.08.017. Epub 2010 Aug 22.
54. Hickey FB, etal., J Am Soc Nephrol. 2011 Aug;22(8):1475-85. doi: 10.1681/ASN.2010111154. Epub 2011 Jul 22.
55. Hu X, etal., Circ Res. 2008 Oct 24;103(9):1009-17. doi: 10.1161/CIRCRESAHA.107.170795. Epub 2008 Sep 18.
56. Hwang SL, etal., Food Funct. 2012 Oct;3(10):1082-90. Epub 2012 Jul 6.
57. Jiang M, etal., Mol Cell Endocrinol. 2013 Mar 7. pii: S0303-7207(13)00076-2. doi: 10.1016/j.mce.2013.02.018.
58. Jiang T, etal., Aging Cell. 2013 Dec;12(6):1021-31. doi: 10.1111/acel.12127. Epub 2013 Jul 29.
59. Jiang X, etal., Mol Cell Endocrinol. 2010 Feb 5;315(1-2):74-80. doi: 10.1016/j.mce.2009.09.018. Epub 2009 Sep 26.
60. Jiang Z, etal., Biol Psychiatry. 2013 Jan 21. pii: S0006-3223(12)01088-8. doi: 10.1016/j.biopsych.2012.12.004.
61. Johri A, etal., Neurodegener Dis. 2011;8(6):496-503. doi: 10.1159/000327910. Epub 2011 Jul 15.
62. Kakuma T, etal., Endocrinology 2000 Dec;141(12):4576-82.
63. Karsenty J, etal., Eur J Nutr. 2013 Dec;52(8):1865-74. doi: 10.1007/s00394-012-0488-0. Epub 2012 Dec 27.
64. Khader A, etal., Transplantation. 2014 Jul 27;98(2):148-56. doi: 10.1097/TP.0000000000000194.
65. Kim DI and Park SH, Biochem Biophys Res Commun. 2013 Jun 14;435(4):702-7. doi: 10.1016/j.bbrc.2013.05.046. Epub 2013 May 18.
66. Kim JW, etal., Endocrinology. 2009 Jun 11.
67. Kim SH, etal., Am J Physiol Endocrinol Metab. 2013 Mar 5.
68. Kusuhara K, etal., Biol Chem. 2007 May;388(5):481-8.
69. Labuzek K, etal., Neurotoxicology. 2010 Jan;31(1):134-46. doi: 10.1016/j.neuro.2009.10.006. Epub 2009 Oct 22.
70. Lai CQ, etal., Diabetes. 2008 Apr;57(4):809-16. Epub 2007 Dec 27.
71. Lai RY, etal., Am J Physiol Cell Physiol. 2010 Jul;299(1):C155-63. doi: 10.1152/ajpcell.00523.2009. Epub 2010 Apr 7.
72. Lane RH, etal., Endocrinology 2002 Jul;143(7):2486-90.
73. Lee MY, etal., Exp Mol Med. 2012 Oct 31;44(10):578-85. doi: 10.3858/emm.2012.44.10.066.
74. Li J, etal., Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):603-14. Epub 2010 Aug 7.
75. Liang H, etal., Muscle Nerve. 2011 Dec;44(6):947-56. doi: 10.1002/mus.22217.
76. Lin J, etal., Cell. 2004 Oct 1;119(1):121-35. doi: 10.1016/j.cell.2004.09.013.
77. Lin YC, etal., Am J Clin Nutr. 2013 Feb;97(2):326-31. doi: 10.3945/ajcn.112.046417. Epub 2012 Dec 26.
78. Ling C, etal., Diabetologia. 2008 Apr;51(4):615-22. Epub 2008 Feb 13.
79. Liu XM, etal., Zhongguo Dang Dai Er Ke Za Zhi. 2008 Apr;10(2):216-20.
80. Louet JF, etal., J Biol Chem 2002 Oct 11;277(41):37991-8000.
81. Marosi K, etal., Neuroscience. 2012 Dec 13;226:21-8. doi: 10.1016/j.neuroscience.2012.09.001. Epub 2012 Sep 12.
82. Martin E, etal., Hum Mol Genet. 2011 Jun 15;20(12):2422-34. doi: 10.1093/hmg/ddr148. Epub 2011 Apr 14.
83. Matiello R, etal., Nutr Metab (Lond). 2010 Apr 30;7:36.
84. Menconi MJ, etal., Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E533-43. Epub 2010 Jul 20.
85. Meng H, etal., Brain Res. 2007 Oct 17;1175:10-6. Epub 2007 Aug 9.
86. MGD data from the GO Consortium
87. Mo L, etal., Free Radic Biol Med. 2012 Oct 1;53(7):1440-50. doi: 10.1016/j.freeradbiomed.2012.07.080. Epub 2012 Aug 4.
88. Muller YL, etal., Diabetes. 2003 Mar;52(3):895-8.
89. Muroya Y, etal., Am J Physiol Renal Physiol. 2012 Oct;303(7):F1070-9. doi: 10.1152/ajprenal.00365.2011. Epub 2012 Aug 8.
90. Naples SP, etal., Appl Physiol Nutr Metab. 2010 Apr;35(2):151-62. doi: 10.1139/H09-139.
91. Naudi A, etal., Rejuvenation Res. 2007 Dec;10(4):473-84.
92. NCBI rat LocusLink and RefSeq merged data July 26, 2002
93. Ndubuizu OI, etal., Brain Res. 2010 Dec 17;1366:101-9. Epub 2010 Sep 25.
94. Oberkofler H, etal., J Biol Chem 2002 May 10;277(19):16750-7.
95. Onishi Y, etal., PLoS One. 2012;7(11):e49189. doi: 10.1371/journal.pone.0049189. Epub 2012 Nov 15.
96. Patel SA, etal., Endocrinology. 2012 Nov;153(11):5231-46. doi: 10.1210/en.2012-1368. Epub 2012 Sep 18.
97. Paternain L, etal., Dis Model Mech. 2012 Sep;5(5):691-7. doi: 10.1242/dmm.009043. Epub 2012 Jul 5.
98. Patki G and Lau YS, Neurosci Lett. 2011 Nov 21;505(3):268-72. Epub 2011 Oct 21.
99. Petrovic V, etal., Comp Biochem Physiol C Toxicol Pharmacol. 2010 Aug;152(2):147-59. doi: 10.1016/j.cbpc.2010.03.008. Epub 2010 Apr 2.
100. Pipeline to import KEGG annotations from KEGG into RGD
101. Pipeline to import Pathway Interaction Database annotations from NCI into RGD
102. Planavila A, etal., Biochim Biophys Acta. 2005 Sep 15;1736(2):120-7.
103. Pooya S, etal., J Hepatol. 2012 Aug;57(2):344-51. doi: 10.1016/j.jhep.2012.03.028. Epub 2012 Apr 17.
104. Prior SL, etal., Dis Markers. 2012;32(6):363-9. doi: 10.3233/DMA-2012-0894.
105. Puddifoot C, etal., J Neurosci. 2012 May 16;32(20):6995-7000.
106. Qin W, etal., Arch Neurol. 2009 Mar;66(3):352-61. doi: 10.1001/archneurol.2008.588.
107. Qu A, etal., Am J Physiol Cell Physiol. 2009 Jun 24.
108. Ramos EM, etal., Hum Genet. 2012 Dec;131(12):1833-40. doi: 10.1007/s00439-012-1205-z. Epub 2012 Jul 25.
109. Rao J, etal., Mol Cell Biochem. 2012 Aug;367(1-2):9-18. doi: 10.1007/s11010-012-1313-z. Epub 2012 Apr 15.
110. Rato L, etal., Biochim Biophys Acta. 2014 Mar;1837(3):335-44. doi: 10.1016/j.bbabio.2013.12.008. Epub 2013 Dec 20.
111. RGD automated data pipeline
112. RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
113. RGD automated import pipeline for gene-chemical interactions
114. Ribel-Madsen R, etal., PLoS One. 2012;7(12):e51302. doi: 10.1371/journal.pone.0051302. Epub 2012 Dec 10.
115. Ringseis R, etal., J Nutr. 2013 Feb;143(2):125-31. doi: 10.3945/jn.112.164038. Epub 2012 Dec 19.
116. Rodriguez-Enriquez S, etal., Autophagy. 2009 Nov;5(8):1099-106. Epub 2009 Nov 13.
117. Ropelle ER, etal., J Physiol. 2009 May 1;587(Pt 9):2069-76. doi: 10.1113/jphysiol.2008.164202. Epub 2009 Mar 9.
118. Roy Chowdhury SK, etal., Brain. 2012 Jun;135(Pt 6):1751-66. doi: 10.1093/brain/aws097. Epub 2012 May 4.
119. Russell LK, etal., Circ Res. 2004 Mar 5;94(4):525-33. Epub 2004 Jan 15.
120. Ryan JJ, etal., Am J Respir Crit Care Med. 2013 Apr 15;187(8):865-78. doi: 10.1164/rccm.201209-1687OC.
121. SanGiovanni JP, etal., PLoS One. 2013;8(1):e53155. doi: 10.1371/journal.pone.0053155. Epub 2013 Jan 15.
122. Santos JM and Kowluru RA, Invest Ophthalmol Vis Sci. 2011 Nov 11;52(12):8791-8. Print 2011.
123. Schlagowski AI, etal., J Appl Physiol (1985). 2014 Feb 15;116(4):364-75. doi: 10.1152/japplphysiol.01177.2013. Epub 2013 Dec 12.
124. Shi J, etal., PLoS One. 2013;8(1):e54054. doi: 10.1371/journal.pone.0054054. Epub 2013 Jan 16.
125. Shin JH, etal., Cell. 2011 Mar 4;144(5):689-702.
126. Siddiqui A, etal., Free Radic Biol Med. 2012 Aug 15;53(4):993-1003. doi: 10.1016/j.freeradbiomed.2012.05.024. Epub 2012 Jun 15.
127. Silveira LR, etal., Biochim Biophys Acta. 2006 Sep;1763(9):969-76. Epub 2006 Jul 7.
128. Sinha RA, etal., Biochem Biophys Res Commun. 2010 Jul 2;397(3):548-52. doi: 10.1016/j.bbrc.2010.05.154. Epub 2010 May 31.
129. Smith BK, etal., J Physiol. 2013 Mar 15;591(Pt 6):1551-61. doi: 10.1113/jphysiol.2012.245944. Epub 2013 Jan 7.
130. Soyal SM, etal., Hum Mol Genet. 2012 May 28.
131. Sullo N, etal., Am J Respir Cell Mol Biol. 2013 Feb;48(2):198-203. doi: 10.1165/rcmb.2012-0167OC. Epub 2012 Nov 9.
132. Sun CK, etal., Crit Care Med. 2009 Apr;37(4):1197-205.
133. Sun M, etal., Cardiovasc Res. 2013 Mar 15;97(4):686-95. doi: 10.1093/cvr/cvs423. Epub 2013 Jan 20.
134. Sung PH, etal., Int Heart J. 2009 Mar;50(2):191-206.
135. Sutherland LN, etal., J Physiol. 2009 Apr 1;587(Pt 7):1607-17. doi: 10.1113/jphysiol.2008.165464. Epub 2009 Feb 16.
136. Suwa M, etal., J Appl Physiol (1985). 2006 Dec;101(6):1685-92. Epub 2006 Aug 10.
137. Szalardy L, etal., Neurodegener Dis. 2013 Feb 13.
138. Taherzadeh-Fard E, etal., Mol Neurodegener. 2011 May 19;6(1):32.
139. Tang DX, etal., Evid Based Complement Alternat Med. 2013;2013:480597. doi: 10.1155/2013/480597. Epub 2013 Feb 26.
140. Terada S, etal., Biochem Biophys Res Commun 2002 Aug 16;296(2):350-4.
141. Thakran S, etal., J Biol Chem. 2013 Jan 11;288(2):807-18. doi: 10.1074/jbc.M112.437970. Epub 2012 Dec 3.
142. Thau N, etal., J Neuropathol Exp Neurol. 2012 Dec;71(12):1064-74. doi: 10.1097/NEN.0b013e318275df4b.
143. Tran M, etal., J Clin Invest. 2011 Oct;121(10):4003-14. doi: 10.1172/JCI58662. Epub 2011 Sep 1.
144. Vazquez F, etal., Cancer Cell. 2013 Feb 12. pii: S1535-6108(13)00034-2. doi: 10.1016/j.ccr.2012.11.020.
145. Vlamings R, etal., Neurobiol Dis. 2012 Dec;48(3):488-94. doi: 10.1016/j.nbd.2012.07.006. Epub 2012 Jul 17.
146. Wadley GD, etal., Am J Physiol Endocrinol Metab. 2008 May;294(5):E861-9. doi: 10.1152/ajpendo.00037.2008. Epub 2008 Mar 4.
147. Wadley GD, etal., Am J Physiol Endocrinol Metab. 2013 Mar 5.
148. Wang CC and Lung FW, Psychiatr Genet. 2012 Apr;22(2):82-7.
149. Weydt P, etal., BMC Neurol. 2014 Jan 2;14:1. doi: 10.1186/1471-2377-14-1.
150. Weydt P, etal., Mol Neurodegener. 2009 Jan 8;4:3. doi: 10.1186/1750-1326-4-3.
151. Wright DC, etal., J Biol Chem. 2007 Jan 5;282(1):194-9. Epub 2006 Nov 12.
152. Wu Y, etal., J Neurotrauma. 2012 May 20;29(8):1663-75. Epub 2012 Apr 16.
153. Xiong S, etal., J Biol Chem. 2010 Jan 22;285(4):2474-87. doi: 10.1074/jbc.M109.065235. Epub 2009 Nov 23.
154. Xu W, etal., Exp Cell Res. 2011 May 1;317(8):1083-92. doi: 10.1016/j.yexcr.2010.10.006. Epub 2010 Oct 15.
155. Xu W, etal., J Cell Physiol. 2012 Sep;227(9):3243-53. doi: 10.1002/jcp.24015.
156. Yang J and Fuller PJ, Mol Cell Endocrinol. 2012 Mar 24;350(2):196-205. doi: 10.1016/j.mce.2011.07.001. Epub 2011 Jul 18.
157. Yang SJ, etal., PLoS One. 2011 Feb 23;6(2):e17057.
158. Yazawa T, etal., Mol Endocrinol. 2010 Mar;24(3):485-96. doi: 10.1210/me.2009-0352. Epub 2010 Feb 4.
159. Yoshizawa T, etal., Hypertension. 2013 Feb;61(2):341-51. doi: 10.1161/HYPERTENSIONAHA.111.00647. Epub 2013 Jan 7.
160. Yu L and Yang SJ, Neuroscience. 2010 Aug 11;169(1):23-38. doi: 10.1016/j.neuroscience.2010.04.063. Epub 2010 May 18.
161. Yu X, etal., Molecules. 2012 Sep 20;17(9):11216-28.
162. Yuan Y, etal., Kidney Int. 2012 Oct;82(7):771-89. doi: 10.1038/ki.2012.188. Epub 2012 May 30.
163. Zhang LN, etal., Diabetes. 2012 Dec 18.
164. Zhang M, etal., Mol Cell Endocrinol. 2012 Nov 5;363(1-2):122-30. doi: 10.1016/j.mce.2012.08.006. Epub 2012 Aug 16.
165. Zhang Y, etal., J Biol Chem. 2004 Dec 24;279(52):53963-71. Epub 2004 Oct 6.
166. Zhao XY, etal., Hear Res. 2013 Feb;296:13-24. doi: 10.1016/j.heares.2012.11.007. Epub 2012 Nov 16.
167. Zheng Z, etal., Diabetes. 2010 Sep;59(9):2315-25. Epub 2010 Jun 21.
168. Zhong Y, etal., Hear Res. 2012 Dec;294(1-2):40-8. doi: 10.1016/j.heares.2012.09.006. Epub 2012 Sep 27.
169. Zhou L, etal., Hepatology. 2012 Nov 23. doi: 10.1002/hep.26167.
170. Zhu L, etal., PLoS One. 2009;4(1):e4182. doi: 10.1371/journal.pone.0004182. Epub 2009 Jan 14.
171. Zhu X, etal., PLoS One. 2012;7(4):e35823. Epub 2012 Apr 23.
Additional References at PubMed
PMID:10913342   PMID:12531492   PMID:12734114   PMID:12821652   PMID:14570700   PMID:14576981   PMID:14744933   PMID:15044597   PMID:15165993   PMID:15199055   PMID:15681609   PMID:15716268  
PMID:15733855   PMID:15967803   PMID:16014350   PMID:16271724   PMID:16352671   PMID:16488887   PMID:16720625   PMID:17239528   PMID:17273866   PMID:17284668   PMID:17476214   PMID:17488713  
PMID:17640976   PMID:17952069   PMID:18555842   PMID:18789599   PMID:18798693   PMID:18972406   PMID:18993053   PMID:19082571   PMID:19179292   PMID:19345188   PMID:19389810   PMID:19542216  
PMID:19651776   PMID:19686839   PMID:19698760   PMID:19766270   PMID:19773550   PMID:19774670   PMID:19774674   PMID:20086200   PMID:20143420   PMID:20359506   PMID:20385772   PMID:20457122  
PMID:20566846   PMID:20661474   PMID:20799369   PMID:20849372   PMID:21106753   PMID:21162799   PMID:21307617   PMID:21536107   PMID:21590341   PMID:21789886   PMID:21972093   PMID:21994947  
PMID:22064484   PMID:22234788   PMID:22237023   PMID:22342160   PMID:22354784   PMID:22461724   PMID:22533417   PMID:22738191   PMID:22899824   PMID:23117952   PMID:23139024   PMID:23212379  
PMID:23292098   PMID:23505321   PMID:23515531   PMID:23525105   PMID:23525500   PMID:23602251   PMID:23635713   PMID:23836911   PMID:23880578   PMID:23948478   PMID:23994518   PMID:24005768  
PMID:24084166   PMID:24096033   PMID:24562467   PMID:24726645   PMID:24898700   PMID:25118933   PMID:25333348   PMID:25402826   PMID:25572651   PMID:25675425   PMID:25824459   PMID:25853493  
PMID:25972379   PMID:26020641   PMID:26054747   PMID:26102301   PMID:26118953   PMID:26287659   PMID:26310573   PMID:26844631   PMID:27076782   PMID:27132229   PMID:27174562   PMID:27178364  
PMID:27302464   PMID:27453548   PMID:27526155   PMID:27793739   PMID:28467933   PMID:28482939   PMID:29383690   PMID:29543139   PMID:29604268   PMID:29901150   PMID:29913155   PMID:30221360  
PMID:30223807   PMID:30396162   PMID:30541949   PMID:30656723   PMID:30664159   PMID:30676864   PMID:31085594   PMID:31238070   PMID:31242648   PMID:31340436   PMID:31471878   PMID:31778153  
PMID:32114097   PMID:32121211   PMID:32305957   PMID:32323734   PMID:32529514   PMID:32851675   PMID:33008083   PMID:33245682   PMID:33268575   PMID:33576345   PMID:33625690   PMID:33661552  
PMID:33847873   PMID:34482051   PMID:34530866   PMID:34576046   PMID:34636198  


Genomics

Comparative Map Data
Ppargc1a
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21458,860,752 - 59,516,525 (+)NCBImRatBN7.2
mRatBN7.2 Ensembl1458,861,144 - 59,512,656 (+)Ensembl
Rnor_6.01463,095,291 - 63,190,688 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1463,095,720 - 63,187,009 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01463,182,479 - 63,286,252 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41464,278,115 - 64,370,912 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11464,280,505 - 64,373,303 (+)NCBI
Celera1458,516,257 - 58,607,916 (+)NCBICelera
Cytogenetic Map14q11NCBI
PPARGC1A
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38423,792,021 - 24,472,905 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl423,755,041 - 23,904,089 (-)EnsemblGRCh38hg38GRCh38
GRCh37423,793,644 - 24,474,528 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36423,402,742 - 23,500,798 (-)NCBINCBI36hg18NCBI36
Build 34423,469,913 - 23,567,969NCBI
Celera424,243,466 - 24,341,439 (-)NCBI
Cytogenetic Map4p15.2NCBI
HuRef423,138,364 - 23,236,560 (-)NCBIHuRef
CHM1_1423,791,582 - 23,889,913 (-)NCBICHM1_1
T2T-CHM13v2.0423,773,791 - 24,454,625 (-)NCBI
Ppargc1a
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39551,611,591 - 52,273,337 (-)NCBIGRCm39mm39
GRCm39 Ensembl551,611,592 - 51,725,068 (-)Ensembl
GRCm38551,454,249 - 52,115,853 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl551,454,250 - 51,567,726 (-)EnsemblGRCm38mm10GRCm38
MGSCv37551,845,488 - 51,945,160 (-)NCBIGRCm37mm9NCBIm37
MGSCv36551,745,901 - 51,842,109 (-)NCBImm8
Celera548,830,811 - 48,929,055 (-)NCBICelera
Cytogenetic Map5C1NCBI
Ppargc1a
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554801,078,322 - 1,188,435 (+)EnsemblChiLan1.0
ChiLan1.0NW_004955480543,397 - 1,188,376 (+)NCBIChiLan1.0ChiLan1.0
PPARGC1A
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
PanPan1.1423,483,377 - 24,160,574 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl423,483,377 - 23,581,212 (-)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v0418,196,431 - 18,876,889 (-)NCBIMhudiblu_PPA_v0panPan3
PPARGC1A
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1385,645,942 - 86,284,570 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl386,016,140 - 86,281,269 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha388,158,508 - 88,796,824 (+)NCBI
ROS_Cfam_1.0386,620,570 - 87,261,415 (+)NCBI
ROS_Cfam_1.0 Ensembl386,992,463 - 87,261,415 (+)Ensembl
UMICH_Zoey_3.1385,752,591 - 86,391,823 (+)NCBI
UNSW_CanFamBas_1.0385,858,991 - 86,497,911 (+)NCBI
UU_Cfam_GSD_1.0386,243,892 - 86,883,362 (+)NCBI
Ppargc1a
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440528551,179,331 - 51,786,516 (+)NCBI
SpeTri2.0NW_0049364774,881,230 - 5,488,208 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
PPARGC1A
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl817,841,844 - 17,961,909 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1817,841,844 - 18,527,953 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Pig Cytomap8p2.1-p2.3NCBI
PPARGC1A
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12725,882,385 - 26,563,530 (+)NCBIChlSab1.1chlSab2
ChlSab1.1 Ensembl2726,465,499 - 26,564,582 (+)EnsemblChlSab1.1chlSab2
Vero_WHO_p1.0NW_02366604772,634,061 - 73,114,795 (+)NCBIVero_WHO_p1.0
Ppargc1a
(Heterocephalus glaber - naked mole-rat)
Naked Mole-rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046247558,375,596 - 8,465,297 (+)EnsemblHetGla_female_1.0hetGla2
HetGla 1.0NW_0046247557,826,219 - 8,460,746 (+)NCBIHetGla_female_1.0hetGla2

Position Markers
MARC_49176-49177:1118326844:1  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21459,495,697 - 59,496,182 (+)MAPPERmRatBN7.2
Rnor_6.01463,169,863 - 63,170,347NCBIRnor6.0
Rnor_5.01463,269,140 - 63,269,624UniSTSRnor5.0
RGSC_v3.41464,352,392 - 64,352,876UniSTSRGSC3.4
Celera1458,590,965 - 58,591,449UniSTS
Cytogenetic Map14q11UniSTS


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1581500Renag1Renal agenesis QTL 1kidney development trait (VT:0000527)percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940)14817066868298175Rat
631839Niddm37Non-insulin dependent diabetes mellitus QTL 373.37blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)141103062295876975Rat
2313397Coatc1Coat color QTL1coat/hair pigmentation trait (VT:0010463)coat/hair color measurement (CMO:0001808)141854133263541332Rat
10755459Coatc15Coat color QTL 150.01681coat/hair pigmentation trait (VT:0010463)pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812)141983694464836944Rat
70187Pancm5Pancreatic morphology QTL 516.7pancreas mass (VT:0010144)pancreas weight to body weight ratio (CMO:0000630)143032009280829842Rat
1300154Bp189Blood pressure QTL 1893.04arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)143088377768757901Rat
2313048Bss84Bone structure and strength QTL 843.10.0001tibia strength trait (VT:1000284)tibia total energy absorbed before break (CMO:0001736)143766971982669719Rat
2313084Bss83Bone structure and strength QTL 832.90.0001tibia size trait (VT:0100001)tibia midshaft endosteal cross-sectional area (CMO:0001716)143766971982669719Rat
2313089Bss81Bone structure and strength QTL 813.40.0001body length (VT:0001256)body length, nose to rump (CMO:0000079)143766971982669719Rat
2313100Bss82Bone structure and strength QTL 8230.0001tibia size trait (VT:0100001)tibia midshaft cross-sectional area (CMO:0001717)143766971982669719Rat
738037Hcas6Hepatocarcinoma susceptibility QTL 62.93liver integrity trait (VT:0010547)liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464)143905723783368335Rat
70214Niddm28Non-insulin dependent diabetes mellitus QTL 284.06blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)143999825175582726Rat
631523Pia13Pristane induced arthritis QTL 133.3joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)144079346098037301Rat
1300136Rf22Renal function QTL 223.9renal blood flow trait (VT:2000006)absolute change in renal vascular resistance (CMO:0001900)144226252995023211Rat
1549834Scl45Serum cholesterol level QTL 455.8blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)145002321195023211Rat
2300197Scl59Serum cholesterol level QTL 59blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)1455147478100147478Rat
9590294Uminl4Urine mineral level QTL 45.660.001urine mineral amount (VT:0015086)urine electrolyte level (CMO:0000593)1455624247100624247Rat
9589034Epfw11Epididymal fat weight QTL 1160.001epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)1455624247100624247Rat
2317879Alcrsp27Alcohol response QTL 273.30.63response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)1456631369101631369Rat
634328Hc5Hypercalciuria QTL 52.3urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1458184885103184885Rat

miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:35
Count of miRNA genes:28
Interacting mature miRNAs:35
Transcripts:ENSRNOT00000006071
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High
Medium 41 1 1 7 8 42 35 2 4 7
Low 3 2 56 41 15 41 1 3 32 38 7 1
Below cutoff 3 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NM_031347 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_008770219 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017599390 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017599391 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092488 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092489 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092490 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092491 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092492 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092493 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039092494 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AB025784 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AY237127 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AY382577 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH473963 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  FQ213484 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  JACYVU010000254 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC227803 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENSRNOT00000006071   ⟹   ENSRNOP00000006071
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1459,421,542 - 59,512,656 (+)Ensembl
Rnor_6.0 Ensembl1463,095,720 - 63,187,009 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000105198   ⟹   ENSRNOP00000076568
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1459,426,456 - 59,512,656 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000108897   ⟹   ENSRNOP00000086053
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1459,421,606 - 59,512,619 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000116869   ⟹   ENSRNOP00000093101
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1458,861,144 - 59,512,656 (+)Ensembl
RefSeq Acc Id: NM_031347   ⟹   NP_112637
RefSeq Status: PROVISIONAL
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,421,606 - 59,512,656 (+)NCBI
Rnor_6.01463,095,827 - 63,186,819 (+)NCBI
Rnor_5.01463,182,479 - 63,286,252 (+)NCBI
RGSC_v3.41464,278,115 - 64,370,912 (+)RGD
Celera1458,516,257 - 58,607,916 (+)RGD
Sequence:
RefSeq Acc Id: XM_039092488   ⟹   XP_038948416
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,421,851 - 59,516,525 (+)NCBI
RefSeq Acc Id: XM_039092489   ⟹   XP_038948417
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,421,414 - 59,516,525 (+)NCBI
RefSeq Acc Id: XM_039092490   ⟹   XP_038948418
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,407,506 - 59,516,525 (+)NCBI
RefSeq Acc Id: XM_039092491   ⟹   XP_038948419
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21458,860,752 - 59,516,525 (+)NCBI
RefSeq Acc Id: XM_039092492   ⟹   XP_038948420
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,421,852 - 59,516,525 (+)NCBI
RefSeq Acc Id: XM_039092493   ⟹   XP_038948421
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,421,858 - 59,516,525 (+)NCBI
RefSeq Acc Id: XM_039092494   ⟹   XP_038948422
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.21459,421,844 - 59,516,525 (+)NCBI
Reference Sequences
RefSeq Acc Id: NP_112637   ⟸   NM_031347
- UniProtKB: Q9QYK2 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: ENSRNOP00000006071   ⟸   ENSRNOT00000006071
RefSeq Acc Id: XP_038948419   ⟸   XM_039092491
- Peptide Label: isoform X4
RefSeq Acc Id: XP_038948418   ⟸   XM_039092490
- Peptide Label: isoform X3
RefSeq Acc Id: XP_038948417   ⟸   XM_039092489
- Peptide Label: isoform X2
RefSeq Acc Id: XP_038948422   ⟸   XM_039092494
- Peptide Label: isoform X7
RefSeq Acc Id: XP_038948416   ⟸   XM_039092488
- Peptide Label: isoform X1
RefSeq Acc Id: XP_038948420   ⟸   XM_039092492
- Peptide Label: isoform X5
RefSeq Acc Id: XP_038948421   ⟸   XM_039092493
- Peptide Label: isoform X6
RefSeq Acc Id: ENSRNOP00000086053   ⟸   ENSRNOT00000108897
RefSeq Acc Id: ENSRNOP00000093101   ⟸   ENSRNOT00000116869
RefSeq Acc Id: ENSRNOP00000076568   ⟸   ENSRNOT00000105198
Protein Domains
RRM

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q9QYK2-F1-model_v2 AlphaFold Q9QYK2 1-796 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13699342
Promoter ID:EPDNEW_R9866
Type:multiple initiation site
Name:Ppargc1a_1
Description:PPARG coactivator 1 alpha
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01463,095,778 - 63,095,838EPDNEW

Strain Variation

Strain Sequence Variants (MRatBN7.2)
ACI/EurMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
ACI/N (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: NIH
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BN-Lx/CubMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BN/NHsdMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BN/NHsdMcwi (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BN/SsN (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: NIH
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BUF/N (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: NIH
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BXH2/CubMcwi (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
BXH3/CubMcwi (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
DA/OlaHsd (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Envigo
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
F344/DuCrl (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Charles River
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
F344/N (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: NIH
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
F344/NCrl (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Charles River
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
F344/Stm (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
FHH/EurMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
FXLE16/Stm (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
FXLE18/Stm (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
GK/FarMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
HXB10/IpcvMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
HXB2/IpcvMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
HXB20/IpcvMcwi (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
HXB31/IpcvMcwi (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
HXB4/IpcvMcwi (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LE/Stm (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEW/Crl (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Charles River
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF10A/StmMcwi (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF11/Stm (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF1A/Stm (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF1C/Stm (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF2B/Stm (2019)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF3/Stm (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LEXF4/Stm (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Japan
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LH/MavRrrcAek (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Kwitek
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LL/MavRrrcAek (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Kwitek
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
LN/MavRrrcAek (2020)
Visual CSV TAB Printer
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.4.1.3.0
Breeder: Kwitek
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
M520/N (2020)
Visual